Day One Biopharmaceuticals, Inc. earnings per share and revenue

DAWN earnings per share for the last quarter are 0.38 USD whereas the estimation was -0.32 USD which accounts for 220.42% surprise. Company revenue for the same period amounts to 93.76 M USD despite the estimated figure of 28.48 M USD. Estimated earnings per share for the next quarter are -0.46 USD, and revenue is expected to reach 27.18 M USD. Also watch annual changes over time to get a bigger picture of DAWN earnings per share and revenue dynamics.